QuantLogix ← IRM scorecard
📅 IRM Earnings Preview
IRM
Next report (est.)
11/04/2026
Countdown
8 days
EPS growth YoY
+326.7%
Revenue growth YoY
+18.5%
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
08/05/2026 ±4.1% +1.3% over-priced
04/30/2026 ±2.7% +10.0% under-priced
02/12/2026 ±3.5% +5.8% under-priced
11/05/2025 ±2.6% -2.8% under-priced
08/06/2025 ±2.3% -5.8% under-priced
05/01/2025 ±2.7% +2.4% over-priced
02/14/2025 ±4.8% +0.2% over-priced
11/06/2024 ±2.5% -9.0% under-priced
Across these reports, options implied an average ±3.1% move vs an actual average of 4.7% — the stock stayed inside the implied band 38% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $0.34 $2.0B $106M
Q1 FY2026 $0.48 $1.9B $149M
Q4 FY2025 — $1.8B $93M
Q3 FY2025 $0.28 $1.8B $86M
Analyst posture
Buy / Strong Buy
15
Hold
1
Sell
1
Stable: +1 net change 30d
Live 5-factor engine read: Buy · 64/100 Full scorecard →
Get alerted before every IRM report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on IRM before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

IRM (IRM) reports in 8 days, with the next report estimated for 11/04/2026. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 4.7% on average — the market has been roughly fair on IRM's earnings risk. Fundamentals into the print: EPS up 326.7% year-over-year, revenue up 18.5%. QuantLogix's live 5-factor engine currently reads IRM as a buy at 64/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →